ENDOSCOPIC AND HISTOLOGIC IMPROVEMENTS WITH PRA023 IN ARTEMIS-UC, A PHASE 2 PLACEBO-CONTROLLED STUDY ON MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Silvio Danese  ¹     Bruce E. Sands  ²     Laurent Peyrin-Biroulet  ³     David T. Rubin  ⁴     Deanna Nguyen  ⁵     Quinn Dinh     Alina Melnyk     J. D. Lu     Bin Dong     Radoslaw Kempinski  ⁶     Timothy Ritter  ⁷     Remo Panaccione  ^8    
1 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milano, Italy
² Icahn School of Medicine at Mount Sinai, New York, United States
³ Last Inserm U954 and CHU de Nancy, Lorraine University, Nancy, France
⁴ University of Chicago Medicine, Chicago, United States
⁵ Prometheus Biosciences, Inc., San Diego, United States
⁶ Wroclaw Medical University, Wroclaw, Poland
⁷ GI Alliance, Southlake, United States
⁸ University of Calgary, Calgary, Canada

Topic
Endoscopy, Histopathology, IBD

Session
The new kids on the block in IBD: Part 2

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)